9p21 dna variants associated coronary artery disease impair interferon-gamma signalling response 
genome-wide association studies identified single nucleotide polymorphisms snps 9p21 gene desert associated coronary artery disease cad1- type diabetes5- despite evidence role associated interval neighbouring gene regulation8- biological underpinnings genetic associations cad type diabetes yet explained identify enhancers 9p21; interval second densest gene desert predicted enhancers six times denser whole genome p < x - cad risk alleles snps rs10811656 rs10757278 located one enhancers disrupt binding site stat1 lymphoblastoid cell lines homozygous cad risk haplotype show binding stat1 lymphoblastoid cell lines homozygous cad non-risk haplotype binding stat1 inhibits cdkn2bas also known cdkn2b-as1 expression reversed short interfering rna knockdown stat1 using new open-ended approach detect long-distance interactions find human vascular endothelial cells enhancer interval containing cad locus physically interacts cdkn2a/b locus mtap gene interval downstream ifna21 human vascular endothelial cells interferon-c activation strongly affects structure chromatin transcriptional regulation 9p21 locus including stat1-binding long-range enhancer interactions altered expression neighbouring genes findings establish link cad genetic susceptibility response inflammatory signalling vascular cell type thus demonstrate utility genome-wide association study findings directing studies novel genomic loci biological processes important disease aetiology 
